TMCI
NASD Treace Medical Concepts, Inc.$4.39 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.39, $0.02 below the day’s high of $4.41
- YTD change
- +79.18%
- vs 20-day SMA
- -3.51%
- vs 200-day SMA
- +43.09%
Price ranges
Price & Performance
+2.95 (+204.86%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 88.2% away from all-time highs of $37.17
- TMCI is up 79% since the beginning of the year
- TMCI is down 30% over the past 12 months
- TMCI is down 7% over the past 1 month
- 4% of all TMCI investors are betting against TMCI
TMCI reads neutral: price sits above one of the two key moving averages, the 12-month move is -31.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -3.30%
- vs 8-day SMA
- -2.47%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Treace Medical Concepts, Inc. engages in the designing, manufacturing, and marketing of orthopedic medical devices and biologic solutions. The firm offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.